Forest Plots of Adverse Effects
For the analysis of efficacy data in clinical drug trials, generally, continuous data are applied. For the analysis of safety data, in contrast, usually proportions of patients with adverse effects are assessed.
The prevalences of adverse effects can be estimated with odds values of patients with adverse effects. The chance of adverse effects of a treatment versus that of a control can be approximated from the ratios of their odds values.